Equity Capital Markets

Company · CIK 1728117

Gossamer Bio, Inc.

CIK1728117 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedGOSS (Nasdaq)
First annual or quarterly report2019-03-22

Offerings

7 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-293009
ShelfEffective
 2026-01-282026-03-182
333-274056
ShelfEffective
 2023-08-182023-08-282
333-274045
ShelfWithdrawn
 2023-08-172023-08-182
333-266701
ShelfEffective
 2022-08-092022-08-091
333-263259
ShelfEffective
 2022-03-032022-03-031
333-237639
ShelfEffective
 2020-04-102020-05-195
333-228984
IPOFinal prospectus
 2018-12-212019-02-085

Filings

19
FiledFilingRegistrationAccession
2026-03-18EFFECTDeclared effective 333-2930099999999995-26-000860
2026-01-28S-3ASRShelf registered 333-2930090001728117-26-000002
2023-08-28EFFECTDeclared effective 333-2740569999999995-23-002516
2023-08-18S-3Shelf registered 333-2740560001728117-23-000116
2023-08-18RWWithdrawn 333-2740450001728117-23-000114
2023-08-17S-3ASRShelf registered 333-2740450001728117-23-000112
2022-08-09S-3ASRShelf registered 333-2667010001728117-22-000086
2022-03-03S-3ASRShelf registered 333-2632590001728117-22-000020
2020-05-19424B5Shelf takedown 333-2376390001564590-20-026207
2020-05-19424B5Shelf takedown 333-2376390001564590-20-026204
2020-05-18424B5Shelf takedown 333-2376390001564590-20-026003
2020-05-18424B5Shelf takedown 333-2376390001564590-20-026001
2020-04-10S-3ASRShelf registered 333-2376390001564590-20-016262
2019-02-08424B4Final prospectus 333-2289840001193125-19-032320
2019-02-07EFFECTDeclared effective 333-2289849999999995-19-000123
2019-01-30S-1/AAmendment 333-2289840001193125-19-022653
2019-01-23S-1/AAmendment 333-2289840001193125-19-014857
2018-12-21S-1Registration filed 333-2289840001193125-18-356444
2018-10-11DRSDraft made public 377-023110000950123-18-009836

All filings of this company · CSV